Meridian Bioscience
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Meridian Bioscience's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5% to $333,018,000. Profit margin reached 13%. Total operating expenses were $112,406,000.

Profit Margin

Meridian Bioscience, Inc. (LSE:0K0K.L): Profit margin
2014 188.83M 34.74M 18.4%
2015 194.83M 35.54M 18.24%
2016 196.08M 32.22M 16.44%
2017 200.77M 21.55M 10.74%
2018 213.57M 23.84M 11.17%
2019 201.01M 24.38M 12.13%
2020 253.66M 46.18M 18.21%
2021 317.89M 71.40M 22.46%
2022 333.01M 42.45M 12.75%

0K0K.L Income Statement (2014 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
333.01M317.89M253.66M201.01M213.57M200.77M196.08M194.83M188.83M
Cost of revenue
144.66M116.74M97.41M82.68M83.11M75.93M68.29M72.94M71.58M
Gross profit
188.35M201.14M156.24M118.32M130.46M124.83M127.78M121.88M117.24M
Operating exp.
Research and development
24.33M23.91M23.72M17.94M16.87M15.68M13.81M12.60M12.55M
Selling and marketing
31.27M26.78M26.48M28.44M34.46M32.10M29.87M25.60M24.91M
Total operating expenses
112.40M107.63M96.64M80.97M85.82M80.82M74.25M65.82M64.85M
Operating income
55.50M93.03M61.32M32.69M31.58M37.38M51.37M56.06M52.39M
Other income (expenses), net
-1.18M-2.58M-2.03M-1.14M-1.20M-953K-734K-997K-284K
Income before tax
54.31M90.45M59.29M31.55M30.38M36.42M50.64M55.06M52.10M
Income tax expense
11.85M19.04M13.10M7.17M6.53M14.87M18.41M19.52M17.36M
Net income
42.45M71.40M46.18M24.38M23.84M21.55M32.22M35.54M34.74M
Earnings per share
Basic EPS
0.961.621.070.570.560.510.770.850.84
Diluted EPS
0.961.621.070.570.560.510.760.850.83
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source